Suk‐Chan Jang

817 total citations
14 papers, 649 citations indexed

About

Suk‐Chan Jang is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Suk‐Chan Jang has authored 14 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Suk‐Chan Jang's work include Cancer Treatment and Pharmacology (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Microtubule and mitosis dynamics (2 papers). Suk‐Chan Jang is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Microtubule and mitosis dynamics (2 papers). Suk‐Chan Jang collaborates with scholars based in South Korea and United States. Suk‐Chan Jang's co-authors include Jogarao Gobburu, Philip M. Colangelo, M. Guillaume Wientjes, Hyo‐Jeong Kuh, Jessie L.‐S. Au, Jianfeng Zheng, Lei Hu, Soo‐Chang Song, J. Lai‐Sim Au and Yuebo Gan and has published in prestigious journals such as Journal of Controlled Release, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Suk‐Chan Jang

13 papers receiving 639 citations

Peers

Countries citing papers authored by Suk‐Chan Jang

Since Specialization

Citations

This map shows the geographic impact of Suk‐Chan Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suk‐Chan Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suk‐Chan Jang more than expected).

Fields of papers citing papers by Suk‐Chan Jang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suk‐Chan Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suk‐Chan Jang. The network helps show where Suk‐Chan Jang may publish in the future.

Co-authorship network of co-authors of Suk‐Chan Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Suk‐Chan Jang. A scholar is included among the top collaborators of Suk‐Chan Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suk‐Chan Jang. Suk‐Chan Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Association between everolimus combination therapy and cancer risk after liver transplantation: A nationwide population-based quasi-cohort study 2025 ·American Journal of Transplantation ·Suk‐Chan Jang, Gi‐Ae Kim, Young‐Suk Lim, Hye‐Lin Kim, Eui‐Kyung Lee	1
2	Development and Validation of a Machine Learning–Based Screening Algorithm to Predict High-Risk Hepatitis C Infection 2025 ·Open Forum Infectious Diseases ·Suk‐Chan Jang, Wei‐Hsuan Lo‐Ciganic, Pilar Hernandez‐Con, (unknown), James L. Huang, (unknown), (unknown), Debbie L. Wilson, (unknown), Faheem W. Guirgis, Robert L. Cook, (unknown), Khoa A. Nguyen, (unknown), Yonghui Wu, David R. Nelson, Haesuk Park	0
3	A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma 2024 ·Frontiers in Oncology ·(unknown), Suk‐Chan Jang, (unknown), Eui‐Kyung Lee, (unknown), Dok Hyun Yoon, (unknown)	1
4	Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis 2022 ·Orphanet Journal of Rare Diseases ·Suk‐Chan Jang, Jin Hyun Nam, Seung‐Ah Lee, (unknown), Hye‐Lin Kim, (unknown), Eui‐Kyung Lee	9
5	Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System 2022 ·Frontiers in Pharmacology ·Suk‐Chan Jang, (unknown), (unknown), (unknown), Eui‐Kyung Lee, Jin Hyun Nam	7
6	Clinical impact and economic burden of post-transplant infections following heart transplantation: A retrospective nationwide cohort study 2022 ·The Journal of Heart and Lung Transplantation ·Suk‐Chan Jang, (unknown), Jin Hyun Nam, Eui‐Kyung Lee, Hye‐Lin Kim, (unknown)	1
7	Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study 2020 ·Expert Opinion on Drug Safety ·(unknown), Suk‐Chan Jang, Ju‐Young Shin	4
8	Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents 2019 ·Antimicrobial Agents and Chemotherapy ·Matthew L. Rizk, Sujata M. Bhavnani, George L. Drusano, Aaron Dane, Ann E. Eakin, Tína Guina, Suk‐Chan Jang, John Tomayko, (unknown), Luning Zhuang, Thomas P. Lodise	37
9	Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma 2010 ·Clinical Pharmacology & Therapeutics ·Suk‐Chan Jang, Philip M. Colangelo, Jogarao Gobburu	196
10	Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006 2007 ·Clinical Pharmacology & Therapeutics ·Venkatesh Atul Bhattaram, Charles R. Bonapace, (unknown), John Duan, Christine Garnett, Jogarao Gobburu, Suk‐Chan Jang, Leslie A. Kenna, Lawrence J. Lesko, (unknown), (unknown), J. Robert Powell, Wei Qiu, R. Ramchandani, Christoffer W. Tornøe, Y Wang, (unknown)	85
11	PIII-74Population pharmacokinetics of propofol in Korean populations 2006 ·Clinical Pharmacology & Therapeutics ·Suk‐Chan Jang, (unknown), (unknown)	1
12	Determinants of drug delivery and transport to solid tumors 2001 ·Journal of Controlled Release ·J. Lai‐Sim Au, Suk‐Chan Jang, Jianfeng Zheng, (unknown), Soo‐Chang Song, Lei Hu, M. Guillaume Wientjes	131
13	Computational Model of Intracellular Pharmacokinetics of Paclitaxel 2000 ·Journal of Pharmacology and Experimental Therapeutics ·Hyo‐Jeong Kuh, Suk‐Chan Jang, M. Guillaume Wientjes, Jessie L.‐S. Au	95
14	Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. 1998 ·PubMed ·Jessie L.‐S. Au, Dong Li, Yuebo Gan, Xiang Gao, Andrew Johnson, Jeffrey S. Johnston, Nancy J. Millenbaugh, Suk‐Chan Jang, Hyo‐Jeong Kuh, (unknown), M. Guillaume Wientjes	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact